MolNFT v1 · #181171 · protein
Receptor for advanced glycation end products VC1 domain in complex with 3-(3-((4-(4-CARBOXYPHENOXY)BENZYL)OXY)PHENYL)-1H-indole-2- carboxylic acid
7LMW · Advanced glycosylation end product-specific receptor: “Receptor for advanced glycation end products VC1 domain in complex with…”. X-ray diffraction, 2 ligands (Y6P, CL), 3 pockets (best druggability 0.48). MolNFT v1 #181171 on…
- PDB
- 7LMW
- Type
- protein
- Length
- 416 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Advanced glycosylation end product-specific receptor
- UniProt
- Q15109
- Ligands
- Y6P, CL
- Pockets
- 3 · best druggability 0.48
Structure
x-ray diffraction · 1 distinct chain · 3% helix, 48% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Advanced glycosylation end product-specific receptor | protein | 208 | 3% helix, 48% strand | Q15109 |
Ligands and binding sites
- Y6P · 7-methyl-3-(1~{H}-pyrazol-4-yl)-1~{H}-indole-2-carboxylic acid · ligand · 6 copies · chains A, B
- CL · Chloride ion · ion · chains B
- ACT · Acetate ion · additive · 5 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 138 | 0.48 | 0.78 | 20 | Y6P |
| 2 | 71 | 0.37 | 0.77 | 21 | empty |
| 3 | 64 | 0.36 | 0.77 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 493 Ų buried · 3 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 7LMW · Receptor for Advanced Glycation End Products VC1 domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
- Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain A against A, TM-score 0.95
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15109
- Elsewhere: RCSB PDB 7LMW · PDBe 7LMW · UniProt Q15109
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.